High Vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Recruiting

Phase 2

High Vs. Standard Dose Influenza Vaccine in Lung Allograft RecipientsHigh Vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Sponsor:

Vanderbilt University Medical Center

Code:

NCT05215327

Conditions

Immunization; Infection

Transplantation Infection

Influenza

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

High Dose Quadrivalent Inactivated Influenza Vaccine

Standard Dose Quadrivalent Inactivated Influenza Vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2024-11-04.